Skip to main content
. 2015 Oct 19;2015:1409.
Ref (type) Population Outcome, Interventions Results and statistical analysis Effect size Favours
Live birth rates

Systematic review
Women with unexplained recurrent miscarriage
8 RCTs in this analysis
Proportion of women having a live birth
92/159 (58%) with intravenous immunoglobulin
85/144 (59%) with placebo

OR 0.98
95% CI 0.61 to 1.58
P = 0.94
This analysis was not ITT
A sensitivity analysis of RCTs reporting an ITT analysis also found no significant difference between groups (4 RCTs, 279 women, OR 1.18, 95% CI 0.72 to 1.93)
See Further information on studies
Not significant

Systematic review
Women with unexplained recurrent miscarriage
6 RCTs in this analysis
Live birth rate per participant randomised
88/139 (63%) with intravenous immunoglobulin
87/133 (65%) with placebo

OR 0.92
95% CI 0.55 to 1.54
P = 0.30
The review also performed a sub-group analysis by type of miscarriage and treatment start time (see Further information on studies)
Not significant